Weiqiang Jing

1.3k total citations · 1 hit paper
23 papers, 674 citations indexed

About

Weiqiang Jing is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Weiqiang Jing has authored 23 papers receiving a total of 674 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 10 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Weiqiang Jing's work include Immune cells in cancer (9 papers), Nanoplatforms for cancer theranostics (3 papers) and interferon and immune responses (2 papers). Weiqiang Jing is often cited by papers focused on Immune cells in cancer (9 papers), Nanoplatforms for cancer theranostics (3 papers) and interferon and immune responses (2 papers). Weiqiang Jing collaborates with scholars based in China, Japan and United States. Weiqiang Jing's co-authors include Jing Zhang, Xinyi Jiang, Peng Sun, Anning Li, Chen Chen, Shengchang Zhang, Wei Du, Ying Liu, Rui Zhang and Yingchao Liu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and Nature Nanotechnology.

In The Last Decade

Weiqiang Jing

23 papers receiving 671 citations

Hit Papers

Immunostimulant hydrogel for the inhibition of malignant ... 2021 2026 2022 2024 2021 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Immunostimulant hydrogel for the inhibition of malignant glioma relapse post-resection
    2021 240 citations Jing Zhang, Chen Chen et al. Nature Nanotechnology profile →

Peers

Weiqiang Jing
Μαρκέλλα Ζαννίκου United States
James W. Opzoomer United Kingdom
Shufang Shen China
Giulia Pellizzari United Kingdom
Kathleen Spring Canada
Kaifan Liang China
Jonathan Rios‐Doria United States
Lanfang Li China
Zhenmei Yang China
Μαρκέλλα Ζαννίκου United States
Weiqiang Jing
Citations per year, relative to Weiqiang Jing Weiqiang Jing (= 1×) peers Μαρκέλλα Ζαννίκου

Countries citing papers authored by Weiqiang Jing

Since Specialization
Citations

This map shows the geographic impact of Weiqiang Jing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiqiang Jing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiqiang Jing more than expected).

Fields of papers citing papers by Weiqiang Jing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiqiang Jing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiqiang Jing. The network helps show where Weiqiang Jing may publish in the future.

Co-authorship network of co-authors of Weiqiang Jing

This figure shows the co-authorship network connecting the top 25 collaborators of Weiqiang Jing. A scholar is included among the top collaborators of Weiqiang Jing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiqiang Jing. Weiqiang Jing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Zengli, Ganyu Wang, Tianli Chen, et al.. (2025). Bile acids activate cancer-associated fibroblasts and induce an immunosuppressive microenvironment in cholangiocarcinoma. Cancer Cell. 43(8). 1460–1475.e10. 5 indexed citations
2.
3.
Jing, Weiqiang, Ganyu Wang, Xinyuan Li, et al.. (2024). Tumor–neutrophil cross talk orchestrates the tumor microenvironment to determine the bladder cancer progression. Proceedings of the National Academy of Sciences. 121(20). 14 indexed citations
4.
Ma, Dapeng, Min Yang, Caiyu Sun, et al.. (2024). cGAS suppresses hepatocellular carcinoma independent of its cGAMP synthase activity. Cell Death and Differentiation. 31(6). 722–737. 9 indexed citations
5.
Liu, Ying, Weiqiang Jing, Jing Zhang, et al.. (2023). In situ MUC1-specific CAR engineering of tumor-supportive macrophages stimulates tumoricidal immunity against pancreatic adenocarcinoma. Nano Today. 49. 101805–101805. 18 indexed citations
6.
Gao, Lin, Chongdeng Shi, Zhenmei Yang, et al.. (2023). Convection-enhanced delivery of nanoencapsulated gene locoregionally yielding ErbB2/Her2-specific CAR-macrophages for brainstem glioma immunotherapy. Journal of Nanobiotechnology. 21(1). 56–56. 47 indexed citations
7.
Jing, Weiqiang, Chen Chen, Ganyu Wang, et al.. (2023). Metabolic Modulation of Intracellular Ammonia via Intravesical Instillation of Nanoporter‐Encased Hydrogel Eradicates Bladder Carcinoma. Advanced Science. 10(12). e2206893–e2206893. 15 indexed citations
8.
Yang, Zhenmei, Ying Liu, Kun Zhao, et al.. (2023). Dual mRNA co-delivery for in situ generation of phagocytosis-enhanced CAR macrophages augments hepatocellular carcinoma immunotherapy. Journal of Controlled Release. 360. 718–733. 62 indexed citations
9.
Lin, Yueke, Xiaoting Lv, Caiyu Sun, et al.. (2022). TRIM50 promotes NLRP3 inflammasome activation by directly inducing NLRP3 oligomerization. EMBO Reports. 23(11). e54569–e54569. 15 indexed citations
10.
Ma, Dapeng, Min Yang, Caiyu Sun, et al.. (2021). Arginine methyltransferase PRMT5 negatively regulates cGAS-mediated antiviral immune response. Science Advances. 7(13). 61 indexed citations
11.
12.
Qin, Jing, Sifeng Qu, Kongkai Zhu, et al.. (2021). Rational design and synthesis of 6-aryl-6H-benzo[c]chromenes as non-steroidal progesterone receptor antagonists for use against cancers. Bioorganic & Medicinal Chemistry. 32. 116003–116003. 6 indexed citations
13.
Zhang, Jing, Chen Chen, Anning Li, et al.. (2021). Immunostimulant hydrogel for the inhibition of malignant glioma relapse post-resection. Nature Nanotechnology. 16(5). 538–548. 240 indexed citations breakdown →
14.
Wang, Ganyu, Weiqiang Jing, Yue Li, et al.. (2021). Neutrophil Elastase Induces Chondrocyte Apoptosis and Facilitates the Occurrence of Osteoarthritis via Caspase Signaling Pathway. Frontiers in Pharmacology. 12. 666162–666162. 32 indexed citations
15.
Sun, Caiyu, Weiqiang Jing, Dapeng Ma, et al.. (2021). Inhibiting Src-mediated PARP1 tyrosine phosphorylation confers synthetic lethality to PARP1 inhibition in HCC. Cancer Letters. 526. 180–192. 15 indexed citations
16.
Wang, Ganyu, et al.. (2021). Anticancer Properties and Mechanisms of Singly-Protonated Dehydronorcantharidin Silver Coordination Polymer in a Bladder Cancer Model. Frontiers in Pharmacology. 12. 618668–618668. 2 indexed citations
17.
Jing, Weiqiang, Xing Guo, Fei Qin, et al.. (2020). G-CSF shifts erythropoiesis from bone marrow into spleen in the setting of systemic inflammation. Life Science Alliance. 4(1). e202000737–e202000737. 8 indexed citations
18.
Jing, Weiqiang, Xing Guo, Ganyu Wang, et al.. (2019). Breast cancer cells promote CD169+ macrophage-associated immunosuppression through JAK2-mediated PD-L1 upregulation on macrophages. International Immunopharmacology. 78. 106012–106012. 48 indexed citations
19.
Jing, Weiqiang, Fei Qin, Xing Guo, et al.. (2018). G-CSF mediates lung injury in mice with adenine-induced acute kidney injury. International Immunopharmacology. 63. 1–8. 6 indexed citations
20.
Jing, Weiqiang, Li Zhang, Fei Qin, et al.. (2017). Targeting macrophages for cancer therapy disrupts bone homeostasis and impairs bone marrow erythropoiesis in mice bearing Lewis lung carcinoma tumors. Cellular Immunology. 331. 168–177. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Μαρκέλλα Ζαννίκου Breakdown of academic impact, for papers by James W. Opzoomer Breakdown of academic impact, for papers by Shufang Shen Breakdown of academic impact, for papers by Giulia Pellizzari Breakdown of academic impact, for papers by Kathleen Spring Breakdown of academic impact, for papers by Kaifan Liang Breakdown of academic impact, for papers by Jonathan Rios‐Doria Breakdown of academic impact, for papers by Lanfang Li Breakdown of academic impact, for papers by Zhenmei Yang
Rankless by CCL
2026